Concepts (53)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 4 | 2024 | 935 | 1.690 |
Why?
|
| Lignans | 2 | 2024 | 21 | 1.630 |
Why?
|
| Furans | 2 | 2024 | 38 | 1.610 |
Why?
|
| Receptors, CCR2 | 1 | 2020 | 26 | 0.730 |
Why?
|
| Exosomes | 1 | 2022 | 101 | 0.720 |
Why?
|
| Tumor Burden | 1 | 2020 | 77 | 0.700 |
Why?
|
| Chemokine CCL2 | 1 | 2020 | 85 | 0.680 |
Why?
|
| Adipose Tissue | 1 | 2020 | 177 | 0.640 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 803 | 0.600 |
Why?
|
| Inflammation | 1 | 2020 | 618 | 0.520 |
Why?
|
| Neoplasms | 1 | 2022 | 1103 | 0.400 |
Why?
|
| Obesity | 1 | 2020 | 1067 | 0.400 |
Why?
|
| Prostate | 2 | 2024 | 154 | 0.370 |
Why?
|
| Animals | 5 | 2024 | 15081 | 0.260 |
Why?
|
| Chemoprevention | 1 | 2024 | 35 | 0.230 |
Why?
|
| Tea | 1 | 2024 | 45 | 0.230 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2024 | 54 | 0.230 |
Why?
|
| Quercetin | 1 | 2024 | 45 | 0.230 |
Why?
|
| Male | 4 | 2024 | 20025 | 0.210 |
Why?
|
| Hormones | 1 | 2022 | 55 | 0.210 |
Why?
|
| Mice | 3 | 2024 | 5913 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 259 | 0.200 |
Why?
|
| Neovascularization, Pathologic | 1 | 2022 | 127 | 0.200 |
Why?
|
| Mice, Knockout | 1 | 2024 | 933 | 0.190 |
Why?
|
| Ligands | 1 | 2022 | 349 | 0.190 |
Why?
|
| Adipokines | 1 | 2020 | 24 | 0.180 |
Why?
|
| Adipocytes | 1 | 2020 | 58 | 0.170 |
Why?
|
| Administration, Oral | 1 | 2020 | 224 | 0.170 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 132 | 0.170 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 126 | 0.170 |
Why?
|
| Models, Biological | 1 | 2022 | 677 | 0.160 |
Why?
|
| Humans | 5 | 2022 | 37093 | 0.150 |
Why?
|
| Curcumin | 1 | 2018 | 74 | 0.150 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 1371 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1039 | 0.140 |
Why?
|
| Glucose | 1 | 2018 | 230 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2022 | 426 | 0.140 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 433 | 0.140 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 2231 | 0.140 |
Why?
|
| Cytokines | 1 | 2020 | 602 | 0.140 |
Why?
|
| Transcription Factors | 1 | 2020 | 681 | 0.120 |
Why?
|
| Apoptosis | 1 | 2022 | 1398 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1198 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 1502 | 0.070 |
Why?
|
| Acetylation | 1 | 2018 | 98 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2018 | 55 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 213 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 601 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 461 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2018 | 339 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 928 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 808 | 0.030 |
Why?
|
| Female | 1 | 2018 | 20969 | 0.010 |
Why?
|